ARTICLE | Company News
Kleo, Peptidream partner to discover and develop immunotherapeutics
August 4, 2017 7:51 PM UTC
PeptiDream Inc. (Tokyo:4587) and Kleo Pharmaceuticals Inc. (New Haven, Conn.) partnered to develop immunotherapeutics.
Peptidream will use its Peptide Discovery Platform System to identify and optimize macrocyclic/constrained peptides against cancer targets selected by Kleo...